Omsana_AM (Amlodipine/Olmesartan Medoxomil) Tablets, U.S.P 5/40mg tablets

1,117

10 People watching this product now!

Payment Methods:

Description

Omsana-AM (Amlodipine 5mg + Olmesartan Medoxomil 40mg) Tablets

Dual-Action Blood Pressure Control for a Healthier Heart

Omsana-AM combines Amlodipine (a calcium channel blocker) and Olmesartan Medoxomil (an angiotensin II receptor blocker – ARB) to provide powerful and long-lasting blood pressure control. This combination relaxes blood vessels, improves circulation, and reduces the workload on the heart, lowering the risk of heart disease, stroke, and kidney complications.

Key Benefits

Effectively Lowers High Blood Pressure – Dual action for enhanced results.
Reduces Risk of Stroke & Heart Attack – Supports overall cardiovascular health.
Relaxes Blood Vessels & Improves Circulation – Ensures better oxygen supply to organs.
Provides 24-Hour Blood Pressure Control – Convenient once-daily dosage.
Well-Tolerated & Suitable for Long-Term Use – Fewer side effects compared to other BP medications.

How to Use

  • Take one tablet daily, or as prescribed by your doctor.
  • Swallow whole with water; do not crush or chew.
  • Can be taken with or without food.
  • Follow a healthy diet and regular exercise routine for the best results.

Important Information

  • May cause dizziness; avoid driving if you feel lightheaded.
  • Monitor blood pressure and kidney function regularly.
  • Not recommended for pregnant women or individuals with severe liver/kidney disease.
  • Avoid excessive salt intake and alcohol consumption.
  • Consult your doctor before use if taking other heart or blood pressure medications.

Omsana-AM is an effective solution for hypertension, helping patients achieve stable blood pressure, improve circulation, and protect heart health for long-term wellness.

Customer Reviews

0 reviews
0
0
0
0
0

There are no reviews yet.

Be the first to review “Omsana_AM (Amlodipine/Olmesartan Medoxomil) Tablets, U.S.P 5/40mg tablets”

Your email address will not be published. Required fields are marked *

1 2 3 4 5
1 2 3 4 5
1 2 3 4 5